Privitera Is New 2nd Vice President of American Epilepsy Society
CINCINNATIMichael Privitera, MD, a professor in the University of Cincinnati (UC) Department of Neurology and Rehabilitation Medicine and director of the Epilepsy Center at the UC Neuroscience Institute (UCNI), has been appointed second vice president of the American Epilepsy Society.
Privitera previously served as treasurer of the society, which is the worlds largest association of professionals dedicated to the prevention, treatment and cure of epilepsy. The announcement was made at the societys 2013 annual meeting, being held in Washington, D.C.
Privitera has been a neurologist specializing in epilepsy and has headed the Epilepsy Center at UCNIone of four centers of excellence at UC Health and the UC College of Medicinefor more than 25 years. He has been a professor of neurology at UC for 14 of those years.
Privitera is an internationally recognized expert on advanced treatments for epilepsy and has dedicated his career to discovering new treatments and caring for people with epilepsy. He established the Epilepsy Center over 25 years ago as the first comprehensive epilepsy program in the region. He has published over 100 scientific articles and a book on epilepsy, and has directed over 50 clinical studies on epilepsy treatment.
Privitera received his undergraduate degree from Johns Hopkins University and his medical degree from the State University of New York-Upstate Medical Center. He completed his residency at Georgetown University and a fellowship at the University of Texas Southwestern Medical Center. He has received numerous awards and honors during his career.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.